Advertisement

Topics

Ironwood’s Duzallo gets FDA approval for gout-associated hyperuricemia

19:00 EDT 21 Aug 2017 | Pharmaceutical Business Review

Ironwood Pharmaceuticals’ Duzallo has been approved by the US Food and Drug Administration (FDA) for the treatment of hyperuricemia in patients with uncontrolled gout.

Original Article: Ironwood’s Duzallo gets FDA approval for gout-associated hyperuricemia

NEXT ARTICLE

More From BioPortfolio on "Ironwood’s Duzallo gets FDA approval for gout-associated hyperuricemia"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...

Gout
According to the National Arthritis Data Workgroup, an estimated 6 million people in the United States report having experienced gout at some point in their lives. In fact, gout is the most common form of inflammatory arthritis in men over the age of 40....